PubRank

A D Lopez

Author PubWeight™ 251.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 44.03
2 Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997 29.18
3 Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997 25.40
4 Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992 25.28
5 Evidence-based health policy--lessons from the Global Burden of Disease Study. Science 1996 13.50
6 Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997 8.25
7 Mortality from smoking worldwide. Br Med Bull 1996 7.87
8 Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997 7.29
9 The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994 6.99
10 The global burden of disease, 1990-2020. Nat Med 1998 6.50
11 Quantifying disability: data, methods and results. Bull World Health Organ 1994 4.99
12 Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 2003 4.94
13 Armed conflict as a public health problem. BMJ 2002 4.42
14 Healthy life expectancy in 191 countries, 1999. Lancet 2001 4.31
15 On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology 1999 3.66
16 The decline in child mortality: a reappraisal. Bull World Health Organ 2000 3.46
17 Global and regional cause-of-death patterns in 1990. Bull World Health Organ 1994 3.37
18 Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ 2000 3.17
19 The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q 1990 2.84
20 The utility of DALYs for public health policy and research: a reply. Bull World Health Organ 1997 2.49
21 Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control 2004 2.12
22 Measuring the burden of disease. Lancet 1998 1.58
23 At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994 1.45
24 Hypertension in developing countries. World Health Stat Q 1988 1.45
25 Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes 1999 1.35
26 Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab 1997 1.33
27 Tobacco or health. World Health Stat Q 1993 1.32
28 KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol 1998 1.26
29 Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol 1986 1.22
30 Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia 2007 1.21
31 An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun 1987 1.19
32 Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol 2000 1.18
33 Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ 1998 1.14
34 Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes 1995 1.13
35 The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ 1996 1.09
36 Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994 1.08
37 On the assessment of maternal mortality. World Health Stat Q 1987 1.04
38 A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab 2000 1.03
39 Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes 1997 1.02
40 Sex differentials in mortality. WHO Chron 1984 1.02
41 Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes 1997 1.00
42 Reducing child mortality. Bull World Health Organ 2000 0.94
43 Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant 1997 0.92
44 Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep 1992 0.91
45 Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia 2003 0.89
46 Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 1999 0.88
47 Developmental gene expression in the human fetal pancreas. Pediatr Res 1994 0.86
48 Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation 1988 0.85
49 Smoking and death in Russia. Tob Control 1998 0.84
50 A note on estimating the cause of death structure in high mortality populations. Popul Bull UN 1982 0.83
51 Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation 1990 0.83
52 Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant 2000 0.81
53 The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res 1991 0.81
54 Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis 2011 0.80
55 Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) 1999 0.80
56 Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol 1989 0.79
57 100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis 2012 0.79
58 Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation 1993 0.78
59 Development of a cell line from the human fetal pancreas. Transplant Proc 1995 0.78
60 Analysis of a human fetal pancreatic islet cell line. Transplant Proc 1997 0.78
61 Health for all: analyzing health status and determinants. World Health Stat Q 1998 0.77
62 Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc 1994 0.77
63 International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci 1990 0.77
64 Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation 1990 0.76
65 In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc 1995 0.76
66 Investigating Australia's burden of disease. Med J Aust 2000 0.75
67 Mortality patterns and trends among the elderly in developed countries. World Health Stat Q 1982 0.75
68 Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed 1984 0.75
69 Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc 1992 0.75
70 [Preventable deaths: general view]. World Health Stat Q 1989 0.75
71 Health projections. Introduction. World Health Stat Q 1984 0.75
72 The impact of demographic trends on health: introduction. World Health Stat Q 1987 0.75
73 Health outlook for South and East Asia for the year 2000. World Health Stat Q 1981 0.75
74 Changing grassroots perception on the family. Rural Reconstr Forum 1995 0.75